Completed OBSERVATIONAL NCT04294550

Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

A Multicenter, Observational Prospective Study on Quality of Life (QOL) in Advanced Cancer Patients With Opioid-induced Constipation (OIC) Treated at Home With Naloxegol According to the Clinical Practice

Sponsor: Fondazione ANT Italia ONLUS

Conditions Cancer Constipation Drug Induced Opioid Use

Interventions Naloxegol

Updated 5 times since 2020 Last updated: Feb 10, 2022 Started: Sep 1, 2018 Primary completion: Dec 31, 2020 Completion: Mar 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04294550, this observational or N/A phase trial focuses on Cancer and Constipation Drug Induced and remains completed. Sponsored by Fondazione ANT Italia ONLUS, it has been updated 5 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Mar 2022 [monthly]

Recruiting
Apr 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione ANT Italia ONLUS

Data source: Fondazione ANT Italia ONLUS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bologna, Italy